Zotefoams PLC Chair Succession (8885M)
January 17 2023 - 1:00AM
UK Regulatory
TIDMZTF
RNS Number : 8885M
Zotefoams PLC
17 January 2023
Zotefoams plc
(the 'Company' or 'Group')
Chair Succession
17 January 2023 - Zotefoams (LSE: ZTF), a world leader in
cellular materials technology, today announces details of changes
to its Board of Directors (the 'Board').
In line with the provisions of the UK Corporate Governance Code,
the term of office of the existing Chair of the Company, Steve
Good, is due to end in 2023. Following an assessment of the Board's
existing skillsets against those required to deliver the Company's
strategy, a search process led by the Senior Independent Director
and supported by Korn Ferry was initiated in mid-2022 to identify
and appoint a new Chair.
The search has been successfully concluded and we are pleased to
announce the appointment of Dr Lynn Drummond as an Independent
Non-Executive Director and Chair Designate.
Lynn is currently Chair and Pro-Chancellor of the University of
Hertfordshire and a Board mentor for Criticaleye. Previously, she
was a Non-Executive Director with Venture Life Group plc, RPC Group
plc, Infirst Healthcare, Shield Holdings AG, Allocate Software plc,
Consort Medical plc and Alimentary Health Ireland. Lynn spent 16
years as a Managing Director within Investment Banking for
Rothschild. Prior to Rothschild, Lynn worked in the Cabinet Office
in London as Private Secretary to the Chief Scientific Advisor. She
has also been Chairman of Trustees for Breast Cancer Haven and was
on the University of Cambridge, Centre for Science and Policy
Development Group. Lynn holds a Bachelor of Science Degree in
Chemistry from the University of Glasgow and a PhD in Biochemistry
from the University of London. She is a Fellow of the Royal Society
of Chemistry and a Fellow of the Royal Society of Edinburgh.
Lynn will take over as Chair following Zotefoams' Annual General
Meeting on 24 May 2023, at which point Steve will retire from the
Board.
Douglas Robertson, Senior Independent Director, said: "On behalf
of the Board, I would like to thank Steve for his significant
contribution to the Zotefoams Group and, in particular, his
leadership as Chair. We wish him the best in his future
endeavours."
David Stirling, Group CEO, said: "I am delighted to welcome Lynn
to Zotefoams. Lynn brings considerable knowledge across a number of
functions and sectors, including a long and distinguished career in
life sciences. She brings extensive and relevant quoted-company
experience and expertise to the Group. I look forward to working
with her as we focus on delivering the next phase of our growth
strategy."
Lynn Drummond said: "Zotefoams is a pioneer in cellular
materials with the purpose of creating optimal material solutions
for the benefit of society. I look forward to working with the
Board as we focus on delivering long-term, sustainable growth in
the interests of all our stakeholders."
There is no further information which would require disclosure
under LR9.6.13 of the Listing Rules of the Financial Conduct
Authority.
Enquiries:
Zotefoams plc +44 (0) 208 664 1600
David Stirling, Group CEO
Gary McGrath, Group CFO
IFC Advisory +44 (0) 203 934 6630
Graham Herring
Tim Metcalfe
Zach Cohen
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular
materials technology delivering optimal material solutions for the
benefit of society. Utilising a variety of unique manufacturing
processes, including environmentally friendly nitrogen expansion
for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance
foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses
its own cellular materials to manufacture T-FIT(R) advanced
insulation for demanding industrial markets. Zotefoams also owns
and licenses patented microcellular foam technology to reduce
plastic use in extrusion applications and for ReZorce(R)
mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional
manufacturing sites in Kentucky, USA, Brzeg, Poland (foam
manufacture), Oklahoma, USA (foam products manufacture and
conversion), Massachusetts, USA, Stilling, Denmark (microcellular
foam technology) and Jiangsu Province, China (T-FIT).
www.zotefoams.com
AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered
trademarks of Zotefoams plc.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAEAXFKFEPDEFA
(END) Dow Jones Newswires
January 17, 2023 02:00 ET (07:00 GMT)
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Apr 2024 to May 2024
Zotefoams (LSE:ZTF)
Historical Stock Chart
From May 2023 to May 2024